Researchers simulated more than 80 million patient encounters, running a variety of models to gain as much insight as possible. Researchers simulated more than 80 million patient encounters, running a variety of models to gain as much insight as possible. | |
|
The risk of post-TAVR pacemaker implantation also goes up when treating elderly patients. The risk of post-TAVR pacemaker implantation also goes up when treating elderly patients. | |
|
The organization is accepting public comments on this topic until May 17. The organization is accepting public comments on this topic until May 17. | |
|
The FDA and CDC announced the recommendation in a new joint statement. Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the United States so far. The FDA and CDC announced the recommendation in a new joint statement. Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the United States so far. | |
|
These blood clots have been responsible for a total of 18 deaths. Experts have continued to emphasize that the benefits of vaccination still outweigh the risks. These blood clots have been responsible for a total of 18 deaths. Experts have continued to emphasize that the benefits of vaccination still outweigh the risks. | |
|
The study, published in Hypertension, included data from more than 8,000 U.S. veterans. The study, published in Hypertension, included data from more than 8,000 U.S. veterans. | |
|
After 24 weeks, treatment with sotatercept was associated with a significant reduction in pulmonary vascular resistance. After 24 weeks, treatment with sotatercept was associated with a significant reduction in pulmonary vascular resistance. | |
|
The analysis, published in Circulation: Cardiovascular Quality and Outcomes, included data from more than 87,000 Medicare patients. The analysis, published in Circulation: Cardiovascular Quality and Outcomes, included data from more than 87,000 Medicare patients. | |
|
Researchers tracked data from more than 1,000 patients who received care from 2014 to 2020. Researchers tracked data from more than 1,000 patients who received care from 2014 to 2020. | |
|
Icosapent ethyl is an FDA-approved medication typically prescribed to limit triglycerides in the blood. Icosapent ethyl is an FDA-approved medication typically prescribed to limit triglycerides in the blood. | |
|